Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1) Antibody

Este producto es parte de LRIG - leucine rich repeats and immunoglobulin like domains
Product Graph
292.5€ (80 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx031198
tested applications
ELISA, WB

Description

LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetLeucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1)
HostRabbit
ReactivityMouse
Recommended DilutionWB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
PurificationPurified through a protein A column, followed by peptide affinity purification.
Size 180 µl
Size 2400 µl
FormLiquid
Tested ApplicationsELISA, WB
BufferPBS containing 0.09% sodium azide.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDQ96JA1
Gene ID26018
OMIM608868
AliasLIG1,LIG-1
BackgroundAntibody anti-LRIG1
StatusRUO

Descripción

LRIG1 is a transmembrane protein characterized by leucine-rich repeats (LRRs) and immunoglobulin-like (Ig-like) domains, which mediate protein-protein interactions. LRIG1 is expressed in various tissues and plays a critical role in regulating cell growth, differentiation, and signaling pathways, particularly in epidermal and neural cells. LRIG1 acts as a negative regulator of receptor tyrosine kinases (RTKs), such as EGFR (epidermal growth factor receptor), by promoting their degradation.  LRIG1 maintains stem cell homeostasis in epithelial tissues, such as the skin and intestines. Dysregulation of LRIG1 expression is linked to cancer progression, where its loss contributes to unchecked cell proliferation and metastasis. Conversely, high LRIG1 levels correlate with better prognosis in certain cancers. LRIG1 also regulates neuronal signaling and plasticity, highlighting its broad functional importance in both development and disease.

Related Products

FNab09953

anti- LRIG1 antibody

Ver Producto
abx031198

Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1) Antibody

LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.

Ver Producto
abx067759

Human Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1) Protein

Recombinant Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).

Ver Producto